3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Gynecologic
1
Classical hematology
1
Breast
1
Conditions
Myelodysplastic Syndromes
13
Anemia, Refractory, with Excess of Blasts
11
Myeloproliferative Disorders
9
Leukemia, Myeloid, Acute
9
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Hematologic Neoplasms
8
Lymphoma, Non-Hodgkin
7
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
7
Anemia, Aplastic
7
Anemia
7
Lymphoma
6
Leukemia, Myelomonocytic, Chronic
6
Leukemia, Lymphocytic, Chronic, B-Cell
6
Multiple Myeloma
5
Leukemia
5
Hodgkin Disease
5
Venous Thromboembolism
4
Primary Myelofibrosis
4
Lymphoma, Mantle-Cell
4
Lymphoma, Follicular
4
Waldenstrom Macroglobulinemia
3
Primary Immunodeficiency Diseases
3
Neoplasms, Plasma Cell
3
Neoplasms
3
Lymphoma, B-Cell, Marginal Zone
3
Burkitt Lymphoma
3
Bone Marrow Failure Disorders
3
Thrombocythemia, Essential
2
Sezary Syndrome
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Toxemia
×
Classical hematology
×
Clear all
NCT06787326
2025-01-22
ONFIRE
Hospital Universitari de Bellvitge
Active not recruiting
228 enrolled